DIFFERENTIATION OF SERUM-CHOLINESTERASE VARIANTS BY SUCCINYLDICHOLINE INHIBITION

被引:41
作者
KING, J
GRIFFIN, D
机构
[1] UNIV GLASGOW,ROY INFIRM,DEPT PATHOL BIOCHEM,GLASGOW,SCOTLAND
[2] UNIV GLASGOW,ROY INFIRM,DEPT BIOCHEM,GLASGOW,SCOTLAND
关键词
D O I
10.1093/bja/45.5.450
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:450 / 454
页数:5
相关论文
共 16 条
[1]  
GARRY PJ, 1971, CLIN CHEM, V17, P183
[2]   EVIDENCE FOR DIFFERENT SILENT GENES IN HUMAN SERUM PSEUDOCHOLINESTERASE POLYMORPHISM [J].
GOEDDE, HW ;
ALTLAND, K .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 151 (A1) :540-&
[3]  
GOEDDE HW, 1968, MOL PHARMACOL, V4, P274
[4]   DIFFERENTIAL INHIBITION OF HUMAN SERUM CHOLINESTERASE WITH FLUORIDE - RECOGNITION OF 2 NEW PHENOTYPES [J].
HARRIS, H ;
WHITTAKER, M .
NATURE, 1961, 191 (478) :496-&
[5]   SUBSTRATE SPECIFICITY OF ATYPICAL CHOLINESTERASE IN RELATION TO PHENOTYPES [J].
IRWIN, RL ;
HEIN, MM .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (02) :145-&
[6]  
KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568
[7]   A METHOD FOR THE DETECTION OF ATYPICAL FORMS OF HUMAN SERUM CHOLINESTERASE - DETERMINATION OF DIBUCAINE NUMBERS [J].
KALOW, W ;
GENEST, K .
CANADIAN JOURNAL OF BIOCHEMISTRY AND PHYSIOLOGY, 1957, 35 (06) :339-346
[8]   THE DISTRIBUTION, DESTRUCTION AND ELIMINATION OF MUSCLE RELAXANTS [J].
KALOW, W .
ANESTHESIOLOGY, 1959, 20 (04) :505-518
[9]  
KALOW W, 1958, BIOCHEM PHARMACOL, V1, P183
[10]  
KALOW W, 1959, CIBA F S BIOCHEMISTR